|
5. TRAITEMENTS
|
|
|
|
5.1 TRAITEMENTS - PRÉ-CLINIQUE
|
|
|
Preventing metastasis - an antibody with therapeutic potential [DKFZ]
|
|
|
|
|
|
Scientists have found out that as cancer progresses, Tie1 helps the blood vessels and tumors to accelerate their growth. In addition, Tie1 destabilizes the walls of the blood vessels and thus promotes the development of metastases. If Tie1 is genetically knocked out in mice, this suppresses both tumor growth and metastasis.
|
|
|
|
|
|
|
5.12.5 IMMUNOTHÉRAPIES - PHARMA
|
|
|
GSK posts middling data from PD-1 Tesaro buyout drug [Fierce Pharma]
|
|
|
|
|
|
The full details are not yet out, but the pharma said its drug had “provided clinically meaningful results” in women with recurrent or advanced mismatch repair-deficient (dMMR) endometrial cancer who progressed on or after a platinum-based regimen. It did not say whether it was statistically significant.
|
|
|
|
|
|
|
|
5.2 PHARMA
|
|
|
|
5.3.4 TRAITEMENTS - AMM (FDA, EMA,...)
|
|
|
|
5.9 AACR
|
|
|
AACR Virtual Annual Meeting I: A User’s Guide [AACR]
|
|
|
|
|
|
This year’s Annual Meeting will take place in two parts, held entirely online. Virtual Annual Meeting I will be held Monday and Tuesday, April 27 and 28. Virtual Annual Meeting II will take place June 22-24. Access to Virtual Annual Meeting I is free, and we look forward to your participation.
|
|
|
|
|
|
|
5.9.3 AACR - MÉLANOME
|
|
|
|
|
6.15 LUTTE CONTRE LES CANCERS - COVID-19
|
|
|
|